Core Viewpoint - Zhongwei Materials (02579) has seen a stock price increase, with a notable rise of over 3% in the morning session, attributed to the announcement of its inclusion in the Stock Connect program starting December 15, 2025 [1] Group 1: Stock Performance - As of the report, Zhongwei Materials' stock price is at 26.92 HKD, with a trading volume of 20.44 million HKD [1] - The stock experienced a rise of 2.36% at the time of reporting [1] Group 2: Business Growth - Changjiang Securities indicates that Zhongwei's business in ternary precursors and cobalt tetroxide is experiencing continuous growth, with an expected growth rate surpassing the industry average [1] - The market share of Zhongwei is on the rise, with expectations for sustained growth in shipments due to the recovery of the ternary precursor market and ongoing growth in cobalt products [1] Group 3: Lithium Resource Development - Zhongwei has established two salt lake lithium mines in Argentina, with an estimated lithium resource exceeding 10 million tons of LCE, which may increase with further exploration [1] - The company plans to confirm the reserves of the lithium mines and will disclose progress in accordance with regulations based on exploration and construction conditions, as well as market demand [1]

中伟新材(02579)公布，根据《上海证券交易所沪港通业务实施办法》和《深圳证券交易所深港通业务 实施办法》的有关规定，公司于香港联合交易所有限公司发行并上市的股票(以下简称"H股")自2025年 12月15日起调入沪港通及深港通标的证券名单。 公告称，公司H股调入港股通标的证券名单后，符合条件的中国内地投资者将可通过上海证券交易所和 深圳证券交易所直接投资公司在香港联合交易所有限公司上市的H股，有利于进一步扩大公司的投资者 基础，并将潜在提高公司H股的交易流动性。 ...

H股获纳入沪港通及深港通后，中国内地的合资格投资者可通过上海证券交易所及深圳证券交易所直接 投资H股。董事会认为，获纳入沪港通及深港通将进一步扩大本公司的投资者基础及增加H股的交易流 通量，从而提升H股的投资价值及本公司于资本市场的声誉。 智通财经APP讯，银诺医药-B(02591)发布公告，根据上海证券交易所及深圳证券交易所分别发出的公 告，本公司H股(H股)获纳入沪港通及深港通(沪港通及深港通)合资格证券名单，自2025年12月8日起生 效。 ...

人民财讯11月12日电，11月12日，在上交所国际投资者大会上，上交所理事长邱勇表示，"十四五"时 期，沪港通累计成交103万亿元，较"十三五"增长288%；新增10家公司完成GDR发行，累计融资33.5亿 美元。 ...

Core Viewpoint - Three companies, Zhongxin Co., Ltd. (603091.SH), Hehe Information (688615.SH), and Yinuosi Biotechnology (688710.SH), will begin trading under the "Shanghai-Hong Kong Stock Connect" mechanism starting October 27, 2025, and will be included as eligible securities in the central settlement system [2] Group 1: Company Information - Zhongxin Co., Ltd. (603091) will be traded under the English name "ZHEJIANG ZHON-A" [2] - Hehe Information (688615) will be traded under the English name "INTSIG INFORM-A" [2] - Yinuosi Biotechnology (688710) will be traded under the English name "SHANGHAI INNO-A" [2] Group 2: Trading Mechanism - The trading of these companies will be conducted in Renminbi and will follow the general rules and operational procedures of Hong Kong settlement [2] - The central settlement system will not provide physical stock custody and withdrawal services for these securities [2]

Core Points - Three companies, Zhongxin Co., Ltd. (603091.SH), Hehe Information (688615.SH), and Innos (688710.SH), will start trading under the "Shanghai-Hong Kong Stock Connect" from October 27, 2025 [1] - These companies will be included as eligible securities in the Central Clearing System, with trading conducted in Renminbi [1] - The Hong Kong Clearing will not provide physical stock custody and withdrawal services for these securities [1] Summary by Category Company Information - Zhongxin Co., Ltd. (603091) will be trading under the English name "ZHEJIANG ZHON-A" [2] - Hehe Information (688615) will be trading under the English name "INTSIG INFORM-A" [2] - Innos (688710) will be trading under the English name "SHANGHAI INNO-A" [2] Trading Mechanism - The trading of these companies will follow the general rules and operational procedures of Hong Kong Clearing [1] - The settlement and clearing will be conducted under the continuous net settlement system of the Central Clearing System [1]

Core Viewpoint - The Hong Kong stock brokerage sector has experienced a significant rebound, with the brokerage index rising 150% over the past decade, reaching a historical high, driven by various market factors and policy changes [1][10]. Group 1: Market Performance and Historical Context - The Hong Kong stock market has undergone approximately seven rounds of brokerage rallies from January 2013 to August 2025, showcasing its volatility and recovery capability [1]. - The first major rally from March 2014 to May 2015 saw the Hong Kong Securities Index increase by 162%, while the Hang Seng Index rose by 32% [4]. - Subsequent rallies included a 21% increase in the Hong Kong Securities Index from February to April 2016 and a 20% increase from December 2017 to January 2018 [5][6]. - The most recent rally from September 2024 to now has resulted in a 151% increase in the Hong Kong Securities Index, with a 40% rise in the Hang Seng Index, indicating a significant outperformance of 111% [9]. Group 2: Factors Driving the Market - The initial rally was fueled by expectations surrounding the Shanghai-Hong Kong Stock Connect, increased corporate financing activities, and a loose liquidity environment [1]. - The second rally was supported by rising international oil prices and policy measures such as reserve requirement cuts in mainland China, alongside the anticipation of the Shenzhen-Hong Kong Stock Connect [2]. - Major policy reforms in 2017, particularly new listing rules by the Hong Kong Stock Exchange, attracted substantial southbound capital and provided new growth drivers for the brokerage sector [3]. - The COVID-19 pandemic in 2020 led to a significant increase in global liquidity, accelerating the return of Chinese concept stocks to Hong Kong, which boosted brokerage business growth [7]. - Recent market improvements have been attributed to favorable policies and enhanced market sentiment, particularly benefiting Chinese brokerages in underwriting and placement activities [8]. Group 3: Future Outlook - The current brokerage market is characterized by significant policy support, active international and domestic capital responses, and rapidly expanding trading volumes [10]. - The valuation of the brokerage sector is recovering quickly, although individual stock performance shows notable divergence, with some stocks still at historical lows and possessing recovery potential [10]. - Future performance of the Hong Kong brokerage sector will be influenced by global liquidity, policy directions, and corporate fundamentals, making it a sector to watch for investment opportunities [10].

Core Viewpoint - The company, Ying'en Biotechnology-B (09606), will be included in the Hang Seng Composite Index and the Hong Kong Stock Connect eligible securities list starting from September 8, 2025, indicating strong market recognition of its performance and value [1] Group 1 - The inclusion in the Hang Seng Composite Index and the Hong Kong Stock Connect will allow qualified investors in mainland China to directly invest in the company's shares listed on the Hong Kong Stock Exchange [1] - This inclusion is expected to further expand the company's investor base and potentially increase the trading liquidity of its shares [1]

Core Viewpoint - The announcement indicates that Ensign Bio-B (09606) will be included in the Hang Seng Composite Index and the Stock Connect program starting September 8, 2025, reflecting strong market recognition of the company's performance and value [1] Group 1 - The inclusion in the Hang Seng Composite Index signifies a high level of recognition from the capital market regarding the company's performance and value [1] - Being added to the Stock Connect program allows qualified investors from mainland China to directly invest in the company's shares listed on the Hong Kong Stock Exchange [1] - This inclusion is expected to further expand the company's investor base and potentially increase the trading liquidity of its shares [1]

Core Points - The Shanghai Composite Index opened high and rose, with the CES300 index increasing by 1.5% to 5259.53 points, with a trading volume of 633.5 billion yuan [1] - The CES300 index has seen a 3.98% increase over the past month, an 8.01% increase over the past three months, and a year-to-date increase of 16.99% [1] - The CES300 index is designed to reflect the overall performance of eligible securities under the "Shanghai-Hong Kong Stock Connect" and "Shenzhen-Hong Kong Stock Connect" [1] Index Holdings - The top ten holdings of the CES300 index include Tencent Holdings (8.77%), Alibaba-W (5.11%), HSBC Holdings (4.03%), Kweichow Moutai (2.27%), Xiaomi Group-W (2.17%), China Construction Bank (2.12%), CATL (1.87%), AIA Group (1.76%), Meituan-W (1.64%), and Ping An Insurance (1.61%) [2] - The market share of the CES300 index holdings is 51.07% from the Hong Kong Stock Exchange, 29.35% from the Shanghai Stock Exchange, and 19.58% from the Shenzhen Stock Exchange [2] - The industry composition of the CES300 index holdings includes Financials (29.42%), Consumer Discretionary (15.15%), Communication Services (14.38%), Information Technology (10.00%), Industrials (8.74%), Consumer Staples (6.06%), Health Care (5.19%), Materials (3.64%), Energy (2.77%), Utilities (2.63%), and Real Estate (2.02%) [2] Tracking Funds - Public funds tracking the CES300 index include Dachen CES300C and Dachen CES300A [3]